Several provinces reported a large number of Chinese Herbal Pieces unqualified
December 4 the grass-roots medical institutions, especially clinics and village clinics, which manage Chinese herbal pieces, should pay attention to these Chinese herbal pieces should not be used. Recently, the drug administration of Shandong Province, Fujian Province and Sichuan Province issued the list of hundreds of batches of unqualified Chinese herbal pieces, most of which are Chinese herbal pieces. On November 28, Shandong Provincial Food and Drug Administration issued the notice of drug quality sampling (issue 6, 2019). According to the notice, 40 varieties and 98 batches of drugs of 62 production enterprises (preparation units) failed to meet the requirements of the standard through sampling inspection. As required, the relevant municipal market supervision and Administration Bureau shall strengthen the supervision of the non-conforming products and the corresponding production and operation enterprises and units, supervise and urge them to find out the causes of the problems, formulate and implement the rectification measures, and effectively eliminate the potential risks. On November 28, Fujian Provincial Drug Administration issued the drug quality announcement (No. 3 in 2019, No. 77 in total). In order to strengthen the drug quality supervision and ensure the public drug safety, according to the drug sampling work plan of Fujian Province, the provincial and municipal drug regulatory departments and drug inspection institutions supervised the drug quality of drug production, trading enterprises and users in Fujian Province. In accordance with the provisions of the drug administration law of the people's Republic of China and the regulations for the implementation of the drug administration law of the people's Republic of China, 49 batches of drugs found in the drug sampling inspection that do not meet the standards are announced. Recently, according to the requirements of the drug sampling plan in 2019, the drug supervision and administration departments of all cities (prefectures) announced the list of 12 batches of unqualified drugs in Sichuan Province The drug production, marketing and use units conducted spot check.
Looking for chemical products? Let suppliers reach out to you!
2026-07-13
-
Life Sciences Industry Overview
The coverage spans the global life sciences industry across pharmaceuticals and food & nutrition, tracking the shift from lowest-cost sourcing to supply continuity, quality, and risk management, along with product trends and the growing edge of differentiated, globally capable players.Published in: June.2026
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
The project of fine chemicals with 4000 t/a Tebuconazole and Diflufenican is to be built
-
Pharmaconex 2022
-
CPHI Korea 2022
-
Shandong Pharmaceutical Companies Grab Over $1 Billion of Antithrombotic Drugs for The First Imitation, Original Research Drugs Soared 5527%
-
ECHEMI International Trade Business School Bangladesh Pharmaceutical Summary
-
Industrialization Progress of genetically modified pharmaceutical products
-
2022 Top 50 Global Pharmaceutical Companies Released! Pfizer Returns to NO.1, Kexing Counterattack First on the List
-
Pharmaceutical and Health Industry Special Study - The Arrival of New Opportunities
-
Accelerate Technological Breakthroughs in Product Innovation and Promote the Industrialization and Application of Innovative Drugs
-
The Rare Disease Market Continues to Heat Up. How Will The Global Top 10 Pharmaceutical Companies by Revenue in 2021 be Deployed?
Recommend Reading
-
The Pill That Could Swallow the Needle: Novo Nordisk Launches Oral Wegovy in U.S. Weight-Loss Revolution
-
The $6 Billion Gold Rush: Generic Semaglutide Set to Reshape Global Pharma After Patent Cliff
-
FDA Names Veteran Oncology Regulator Pazdur as Director of Drug Review Center
-
MENA Pharmaceutical Regulatory Updates 2026: Key Compliance Changes for Global Pharma Companies
-
Pharma Tariff Risk Pushes Global Drugmakers to Rebuild U.S. Supply Chains
-
Crude Oil Surge Leads to Significant Increase in This Round of Retail Fuel Prices in China
-
In August, the Chinese soda ash market continued to decline
-
Hexane in Food and Industry: Safety and Applications
-
This Week's Acetic Acid Market Shows Weakness and Decline (2.1-2.6)
-
China's Phenol Market Surges 62% in 9 Days